Europe Biosimilar Drug Market Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 128
Inquire Before Buying

Notes:

Sales, means the sales volume of Biosimilar Drug

Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Hospira

- Sandoz

- Teva Pharmaceutical Industries

- Pfizer

- Merck Sharp & Dohme

- Celltrion

- Amgen

- Biogen

- Mylan

- Biocon

- Dr. Reddy's Laboratories

- Boehringer Ingelheim GmbH

- Intas Pharmaceuticals

- LG Life Sciences

- Emcure Pharmaceuticals

- Probiomed

- Biosidus

- 3SBio

- WOCKHARDT

- Sun Pharmaceutical Industries

- Shanghai Fosun Pharmaceutical

- Qilu Pharmaceutical

- Allergan

- Dongbao

- Samsung Biologics

- Zydus Cadila.

- Dong-A Pharmaceutical

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilar Drug in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Biosimilar Drug Market Report 2016

Table of Contents
Europe Biosimilar Drug Market Report 2016
1 Biosimilar Drug Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Biosimilar Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Biosimilar Drug Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Biosimilar Drug (2011-2021)
1.5.1 Europe Biosimilar Drug Sales and Growth Rate (2011-2021)
1.5.2 Europe Biosimilar Drug Revenue and Growth Rate (2011-2021)
2 Europe Biosimilar Drug by Manufacturers, Type and Application
2.1 Europe Biosimilar Drug Market Competition by Manufacturers
2.1.1 Europe Biosimilar Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Biosimilar Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Biosimilar Drug (Volume and Value) by Type
2.2.1 Europe Biosimilar Drug Sales and Market Share by Type (2011-2016)
2.2.2 Europe Biosimilar Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Biosimilar Drug (Volume and Value) by Countries
2.3.1 Europe Biosimilar Drug Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Biosimilar Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Biosimilar Drug (Volume) by Application
3 Germany Biosimilar Drug (Volume, Value and Sales Price)
3.1 Germany Biosimilar Drug Sales and Value (2011-2016)
3.1.1 Germany Biosimilar Drug Sales and Growth Rate (2011-2016)
3.1.2 Germany Biosimilar Drug Revenue and Growth Rate (2011-2016)
3.1.3 Germany Biosimilar Drug Sales Price Trend (2011-2016)
3.2 Germany Biosimilar Drug Sales and Market Share by Manufacturers
3.3 Germany Biosimilar Drug Sales and Market Share by Type
3.4 Germany Biosimilar Drug Sales and Market Share by Application
4 France Biosimilar Drug (Volume, Value and Sales Price)
4.1 France Biosimilar Drug Sales and Value (2011-2016)
4.1.1 France Biosimilar Drug Sales and Growth Rate (2011-2016)
4.1.2 France Biosimilar Drug Revenue and Growth Rate (2011-2016)
4.1.4 France Biosimilar Drug Sales Price Trend (2011-2016)
4.2 France Biosimilar Drug Sales and Market Share by Manufacturers
4.3 France Biosimilar Drug Sales and Market Share by Type
4.4 France Biosimilar Drug Sales and Market Share by Application
5 UK Biosimilar Drug (Volume, Value and Sales Price)
5.1 UK Biosimilar Drug Sales and Value (2011-2016)
5.1.1 UK Biosimilar Drug Sales and Growth Rate (2011-2016)
5.1.2 UK Biosimilar Drug Revenue and Growth Rate (2011-2016)
5.1.5 UK Biosimilar Drug Sales Price Trend (2011-2016)
5.2 UK Biosimilar Drug Sales and Market Share by Manufacturers
5.3 UK Biosimilar Drug Sales and Market Share by Type
5.4 UK Biosimilar Drug Sales and Market Share by Application
6 Russia Biosimilar Drug (Volume, Value and Sales Price)
6.1 Russia Biosimilar Drug Sales and Value (2011-2016)
6.1.1 Russia Biosimilar Drug Sales and Growth Rate (2011-2016)
6.1.2 Russia Biosimilar Drug Revenue and Growth Rate (2011-2016)
6.1.6 Russia Biosimilar Drug Sales Price Trend (2011-2016)
6.2 Russia Biosimilar Drug Sales and Market Share by Manufacturers
6.3 Russia Biosimilar Drug Sales and Market Share by Type
6.4 Russia Biosimilar Drug Sales and Market Share by Application
7 Italy Biosimilar Drug (Volume, Value and Sales Price)
7.1 Italy Biosimilar Drug Sales and Value (2011-2016)
7.1.1 Italy Biosimilar Drug Sales and Growth Rate (2011-2016)
7.1.2 Italy Biosimilar Drug Revenue and Growth Rate (2011-2016)
7.1.7 Italy Biosimilar Drug Sales Price Trend (2011-2016)
7.2 Italy Biosimilar Drug Sales and Market Share by Manufacturers
7.3 Italy Biosimilar Drug Sales and Market Share by Type
7.4 Italy Biosimilar Drug Sales and Market Share by Application
8 Spain Biosimilar Drug (Volume, Value and Sales Price)
8.1 Spain Biosimilar Drug Sales and Value (2011-2016)
8.1.1 Spain Biosimilar Drug Sales and Growth Rate (2011-2016)
8.1.2 Spain Biosimilar Drug Revenue and Growth Rate (2011-2016)
8.1.8 Spain Biosimilar Drug Sales Price Trend (2011-2016)
8.2 Spain Biosimilar Drug Sales and Market Share by Manufacturers
8.3 Spain Biosimilar Drug Sales and Market Share by Type
8.4 Spain Biosimilar Drug Sales and Market Share by Application
9 Benelux Biosimilar Drug (Volume, Value and Sales Price)
9.1 Benelux Biosimilar Drug Sales and Value (2011-2016)
9.1.1 Benelux Biosimilar Drug Sales and Growth Rate (2011-2016)
9.1.2 Benelux Biosimilar Drug Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Biosimilar Drug Sales Price Trend (2011-2016)
9.2 Benelux Biosimilar Drug Sales and Market Share by Manufacturers
9.3 Benelux Biosimilar Drug Sales and Market Share by Type
9.4 Benelux Biosimilar Drug Sales and Market Share by Application
10 Europe Biosimilar Drug Manufacturers Analysis
10.1 Hospira
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Biosimilar Drug Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Hospira Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Sandoz
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Biosimilar Drug Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Teva Pharmaceutical Industries
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Biosimilar Drug Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Teva Pharmaceutical Industries Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Pfizer
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Biosimilar Drug Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Pfizer Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Merck Sharp & Dohme
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Biosimilar Drug Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Merck Sharp & Dohme Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Celltrion
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Biosimilar Drug Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Celltrion Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Amgen
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Biosimilar Drug Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Biogen
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Biosimilar Drug Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Biogen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Mylan
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Biosimilar Drug Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Mylan Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Biocon
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Biosimilar Drug Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Biocon Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Dr. Reddy's Laboratories
10.12 Boehringer Ingelheim GmbH
10.13 Intas Pharmaceuticals
10.14 LG Life Sciences
10.15 Emcure Pharmaceuticals
10.16 Probiomed
10.17 Biosidus
10.18 3SBio
10.19 WOCKHARDT
10.20 Sun Pharmaceutical Industries
10.21 Shanghai Fosun Pharmaceutical
10.22 Qilu Pharmaceutical
10.23 Allergan
10.24 Dongbao
10.25 Samsung Biologics
10.26 Zydus Cadila.
10.27 Dong-A Pharmaceutical
11 Biosimilar Drug Manufacturing Cost Analysis
11.1 Biosimilar Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biosimilar Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Biosimilar Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Biosimilar Drug Market Forecast (2016-2021)
14.1 Germany Biosimilar Drug Sales Forecast (2016-2021)
14.2 France Biosimilar Drug Sales Forecast (2016-2021)
14.3 UK Biosimilar Drug Sales Forecast (2016-2021)
14.4 Russia Biosimilar Drug Sales Forecast (2016-2021)
14.5 Italy Biosimilar Drug Sales Forecast (2016-2021)
14.6 Spain Biosimilar Drug Sales Forecast (2016-2021)
14.7 Benelux Biosimilar Drug Sales Forecast (2016-2021)
14.8 Europe Biosimilar Drug Sales Forecast by Type (2016-2021)
14.9 Europe Biosimilar Drug Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Europe Sales Market Share of Biosimilar Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Biosimilar Drug
Figure Europe Sales Market Share of Biosimilar Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure France Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure UK Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure Russia Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure Italy Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure Spain Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Biosimilar Drug Revenue and Growth Rate (2011-2021)
Figure Europe Biosimilar Drug Sales and Growth Rate (2011-2021)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2011-2021)
Table Europe Biosimilar Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Biosimilar Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table Europe Biosimilar Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Biosimilar Drug Revenue Share by Manufacturers
Table 2016 Europe Biosimilar Drug Revenue Share by Manufacturers
Table Europe Biosimilar Drug Sales and Market Share by Type (2011-2016)
Table Europe Biosimilar Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Biosimilar Drug by Type (2011-2016)
Figure Europe Biosimilar Drug Sales Growth Rate by Type (2011-2016)
Table Europe Biosimilar Drug Revenue and Market Share by Type (2011-2016)
Table Europe Biosimilar Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilar Drug by Type (2011-2016)
Figure Europe Biosimilar Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Biosimilar Drug Sales and Market Share by Countries (2011-2016)
Table Europe Biosimilar Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Biosimilar Drug by Countries (2011-2016)
Table Europe Biosimilar Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Biosimilar Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Biosimilar Drug by Countries (2011-2016)
Table Europe Biosimilar Drug Sales and Market Share by Application (2011-2016)
Table Europe Biosimilar Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Biosimilar Drug by Application (2011-2016)
Figure Germany Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure Germany Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure Germany Biosimilar Drug Sales Price Trend (2011-2016)
Table Germany Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table Germany Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Biosimilar Drug Sales by Type (2015 and 2016)
Table Germany Biosimilar Drug Market Share by Type (2015 and 2016)
Table Germany Biosimilar Drug Sales by Application (2015 and 2016)
Table Germany Biosimilar Drug Market Share by Application (2015 and 2016)
Figure France Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure France Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure France Biosimilar Drug Sales Price Trend (2011-2016)
Table France Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table France Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table France Biosimilar Drug Sales by Type (2015 and 2016)
Table France Biosimilar Drug Market Share by Type (2015 and 2016)
Table France Biosimilar Drug Sales by Application (2015 and 2016)
Table France Biosimilar Drug Market Share by Application (2015 and 2016)
Figure UK Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure UK Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure UK Biosimilar Drug Sales Price Trend (2011-2016)
Table UK Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table UK Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table UK Biosimilar Drug Sales by Type (2015 and 2016)
Table UK Biosimilar Drug Market Share by Type (2015 and 2016)
Table UK Biosimilar Drug Sales by Application (2015 and 2016)
Table UK Biosimilar Drug Market Share by Application (2015 and 2016)
Figure Russia Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure Russia Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure Russia Biosimilar Drug Sales Price Trend (2011-2016)
Table Russia Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table Russia Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Biosimilar Drug Sales by Type (2015 and 2016)
Table Russia Biosimilar Drug Market Share by Type (2015 and 2016)
Table Russia Biosimilar Drug Sales by Application (2015 and 2016)
Table Russia Biosimilar Drug Market Share by Application (2015 and 2016)
Figure Italy Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure Italy Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure Italy Biosimilar Drug Sales Price Trend (2011-2016)
Table Italy Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table Italy Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Biosimilar Drug Sales by Type (2015 and 2016)
Table Italy Biosimilar Drug Market Share by Type (2015 and 2016)
Table Italy Biosimilar Drug Sales by Application (2015 and 2016)
Table Italy Biosimilar Drug Market Share by Application (2015 and 2016)
Figure Spain Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure Spain Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure Spain Biosimilar Drug Sales Price Trend (2011-2016)
Table Spain Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table Spain Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Biosimilar Drug Sales by Type (2015 and 2016)
Table Spain Biosimilar Drug Market Share by Type (2015 and 2016)
Table Spain Biosimilar Drug Sales by Application (2015 and 2016)
Table Spain Biosimilar Drug Market Share by Application (2015 and 2016)
Figure Benelux Biosimilar Drug Sales and Growth Rate (2011-2016)
Figure Benelux Biosimilar Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Biosimilar Drug Sales Price Trend (2011-2016)
Table Benelux Biosimilar Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Biosimilar Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Biosimilar Drug Sales by Type (2015 and 2016)
Table Benelux Biosimilar Drug Market Share by Type (2015 and 2016)
Table Benelux Biosimilar Drug Sales by Application (2015 and 2016)
Table Benelux Biosimilar Drug Market Share by Application (2015 and 2016)
Table Biosimilar Drug Basic Information List
Table Hospira Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Biosimilar Drug Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Biosimilar Drug Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Biosimilar Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Biosimilar Drug Sales Market Share (2011-2016)
Table Merck Sharp & Dohme Basic Information List
Table Merck Sharp & Dohme Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Sharp & Dohme Biosimilar Drug Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Biosimilar Drug Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilar Drug Sales Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Biosimilar Drug Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Biosimilar Drug Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Biosimilar Drug Sales Market Share (2011-2016)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy's Laboratories Biosimilar Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH Biosimilar Drug Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Biosimilar Drug Sales Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Biosimilar Drug Sales Market Share (2011-2016)
Table Emcure Pharmaceuticals Basic Information List
Table Emcure Pharmaceuticals Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emcure Pharmaceuticals Biosimilar Drug Sales Market Share (2011-2016)
Table Probiomed Basic Information List
Table Probiomed Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Probiomed Biosimilar Drug Sales Market Share (2011-2016)
Table Biosidus Basic Information List
Table Biosidus Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biosidus Biosimilar Drug Sales Market Share (2011-2016)
Table 3SBio Basic Information List
Table 3SBio Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3SBio Biosimilar Drug Sales Market Share (2011-2016)
Table WOCKHARDT Basic Information List
Table WOCKHARDT Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table WOCKHARDT Biosimilar Drug Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Biosimilar Drug Sales Market Share (2011-2016)
Table Shanghai Fosun Pharmaceutical Basic Information List
Table Shanghai Fosun Pharmaceutical Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Fosun Pharmaceutical Biosimilar Drug Sales Market Share (2011-2016)
Table Qilu Pharmaceutical Basic Information List
Table Qilu Pharmaceutical Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qilu Pharmaceutical Biosimilar Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Biosimilar Drug Sales Market Share (2011-2016)
Table Dongbao Basic Information List
Table Dongbao Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dongbao Biosimilar Drug Sales Market Share (2011-2016)
Table Samsung Biologics Basic Information List
Table Samsung Biologics Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Biologics Biosimilar Drug Sales Market Share (2011-2016)
Table Zydus Cadila. Basic Information List
Table Zydus Cadila. Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila. Biosimilar Drug Sales Market Share (2011-2016)
Table Dong-A Pharmaceutical Basic Information List
Table Dong-A Pharmaceutical Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dong-A Pharmaceutical Biosimilar Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure Germany Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Biosimilar Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Biosimilar Drug Sales Forecast by Type (2016-2021)
Table Europe Biosimilar Drug Sales Forecast by Application (2016-2021)
  • Global Bacillus Subtilis Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Mar-2017        Price: US 3480 Onwards        Pages: 117
    Bacillus subtilis, known also as the hay bacillus or grass bacillus, is a Gram-positive, catalase-positive bacterium, found in soil and the gastrointestinal tract of ruminants and humans. A member of the genus Bacillus, B. subtilis is rod-shaped, and can form a tough, protective endospore, allowing it to tolerate extreme environmental conditions. B. subtilis has historically been classified as an obligate aerobe, though evidence exists that it is a facultative aerobe. B. subtilis is considered t......
  • Asia-Pacific Plasminogen Activator Inhibitor Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Plasminogen Activator Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Plasminogen Activator Inhibitor for these regions, from 2012 to 2022 (forecast), including - China - Japan......
  • Asia-Pacific Natriuretic Peptide Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Natriuretic Peptide for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea -......
  • Asia-Pacific Demineralized Bone Matrix Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Demineralized Bone Matrix market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Demineralized Bone Matrix for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Ko......
  • Asia-Pacific Creatine Kinase Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Creatine Kinase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Creatine Kinase for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Cardiac Troponin Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Cardiac Troponin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Cardiac Troponin for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwa......
  • Asia-Pacific Argatroban Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the Asia-Pacific Argatroban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Argatroban for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan - I......
  • EMEA (Europe, Middle East and Africa) Herbal Oil Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Herbal Oil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Herbal Oil for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Veterinary Pain Management Drugs Market Report 2017
    Published: 23-Mar-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Veterinary Pain Management Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs